🚀 We are delighted to announce that we have been chosen as winners of the Women TechEU grant and business development programme! This programme not only supports cutting-edge innovation but also empowers women in leadership positions, driving diversity and inclusion in the tech industry. A huge thank you to our team, partners, and supporters who make this journey possible. We are excited to leverage this opportunity to accelerate our impact and continue breaking barriers! #WomenInLeadership #WomenInTech #Innovation #Entrepreneurship #DiversityInTech #WomenTechEU Marie Schiltz Meghan Perkins, PhD
À propos
At Proskope, we are on a mission to transform cancer detection and treatment with our breakthrough innovation. With the alarming increase in cancer cases worldwide and the financial burden associated with their treatment, it is more important than ever to find effective new ways to detect cancer early, when it can be cured. Our work is the result of joint research efforts by a multidisciplinary team from France and England, with expertise in cancer cell biology and cell imaging software. The test is non-invasive (based on a blood sample), sensitive, quick and cost effective. Our team is currently focused on designing and manufacturing a fully automated version of the product to confirm its effectiveness through larger scale clinical trials. If you are passionate about making a difference in the world of healthcare and believe in the power of technology to transform cancer detection and treatment, join us in our mission. Do not hesitate to contact us to learn more about Proskope!
- Secteur
- Recherche en biotechnologie
- Taille de l’entreprise
- 2-10 employés
- Siège social
- Paris
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2022
- Domaines
- In vitro diagnostics, cancer diagnostics et biotechnology
Lieux
-
Principal
Paris, FR
Nouvelles
-
🎉 Thrilled to announce that Proskope has been preselected to join the MATWIN 𝗦𝗧𝗔𝗥𝗧 Acceleration program! 🚀 We are honoured to be part of this incredible initiative supporting innovative oncology projects with high potential. Over the next 6 months, we’ll benefit from strategic guidance, top-tier scientific and industrial expertise, and an invaluable platform to bring our innovation closer to transforming patient care. A big thank you to MATWIN for this opportunity and congratulations to the 15 other inspiring projects selected—we’re in excellent company! Let’s work together to drive groundbreaking progress in the fight against #cancer. Here’s to making a difference! 💪 Marie Schiltz Meghan Perkins, PhD Michaël Niddam
🎉Congrats to the 16 projects preselected to join & enjoy the MATWIN 𝗦𝗧𝗔𝗥𝗧 Acceleration program!🚀 The START program supports innovative oncology projects with high potential, offering them unique strategic support over 6 months to accelerate their development. Thanks to high-level scientific and industrial expertise, these projects benefit from a real springboard to transform their innovations into concrete solutions for patients. 👏 Many thanks to all applicants for their participation, and congratulations to the winners! These 16 promising projects illustrate the excellence of oncology research, and testify to MATWIN's ability to drive a collaborative dynamic on cancer innovation on a European scale! Let's accelerate these medical innovations against #cancer ! Welcome 🔹aubin Penna Université de Poitiers 🔹Nataliya Yeremenko Nantes Université 🔹Dominique HEYMANN Sylvia Colliec-Jouault Nantes Université Institut de Cancérologie de l'Ouest (ICO) Ifremer SATT Ouest Valorisation 🔹Laurent Fontaine Anne-Caroline CHANY Le Mans Université 🔹@Michal Tichý IOCB Prague - Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences 🔹Bert M. Klebl Lead Discovery Center GmbH 🔹Coralie Dorard Actipulse Neuroscience® 🔹Jonathan Naccache, PhD Brink Therapeutics 🔹Anne Lecadieu Elisabeth Auzias Nicolas Wolikow Cure51 🔹Isabel Marey-Semper Doxanano 🔹Rémi Rosière Frédéric De Coninck InhaTarget Therapeutics 🔹Cyril GILBERT Kimialys 🔹Hedi Ben Brahim One Biosciences 🔹Marie Schiltz Proskope 🔹Mathilde Coustets see2cure 🔹Alexandre Hill Serendip innovations 👉 To learn more about the MATWIN program : https://lnkd.in/gCzFDeF #Innovation #Oncology #Startup #MATWIN #cancer #health Unicancer
-
-
🎉 Exciting news! We’re thrilled to share that Proskope has been selected for the prestigious #OncoEntrepreneur 2024-2025 program by the Paris Saclay Cancer Cluster (PSCC)! 🚀 This incredible initiative, part of the OncoSTART consortium, offers tailored training designed to empower the next generation of oncology innovators. We are proud to contribute to this journey and look forward to learning, collaborating, and accelerating impactful solutions for oncology patients worldwide. 💡 Huge congratulations to all the talented participants—let’s make a difference together! #Innovation #Oncology #Entrepreneurship #OncoSTART #PSCC Marie Schiltz Meghan Perkins, PhD Michaël Niddam
🎉 𝗟𝗮 𝗻𝗼𝘂𝘃𝗲𝗹𝗹𝗲 𝗽𝗿𝗼𝗺𝗼𝘁𝗶𝗼𝗻 #𝗢𝗻𝗰𝗼𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿 𝟮𝟬𝟮𝟰-𝟮𝟬𝟮𝟱 𝗲𝘀𝘁 𝗱𝗲́𝘃𝗼𝗶𝗹𝗲́𝗲 ! Le Paris Saclay Cancer Cluster (PSCC) est ravi de présenter les 18 projets innovants sélectionnés pour le programme #OncoEntrepreneur, qui s'inscrit dans le cadre du consortium OncoSTART. Le programme #Oncoentrepreneur du PSCC propose une formation dédiée pour les futurs entrepreneurs en oncologie, avec près de 30 sessions couvrant tous les aspects de la création d'entreprise, des pactes d'actionnaires à l'accès au marché. Les projets sélectionnés disposeront de masterclasses pour acquérir les compétences essentielles et se connecter à un réseau d’experts et d’acteurs de l’écosystème. 💡 𝗟𝗲𝘀 𝟭𝟴 𝗽𝗿𝗼𝗷𝗲𝘁𝘀 𝗲𝗻 𝗯𝗶𝗼𝘁𝗲𝗰𝗵, 𝗺𝗲𝗱𝘁𝗲𝗰𝗵 𝗲𝘁 𝗲-𝘀𝗮𝗻𝘁𝗲́, portés par des chercheurs, cliniciens, entrepreneurs et étudiants, bénéficieront ainsi d’une formation de 7 mois constituée de sessions hebdomadaires. 👏 Félicitations aux talents sélectionnés : Mehdi Nasreddine-Royer, Mandy Kadoche, Pascale BERTHET, Sébastien Vachenc, Nicolas Babault, Timothée ZEMMOUR, Mohamed DEBBAH, Olivier Huillard, Christa Sempertegui, Sidarth Radjou, Laure-Hélène Mercier, Jean-Claude Gerbedoen, Guillaume BLANC, Manale Karam (Doldur), Yannick Kizito, pascal LEURAUD Marie Schiltz, Marie Destobbeleir 🚀 Ensemble, accélerons l’innovation en oncologie !
-
-
🚀 Big News Alert! 🚀 We're thrilled to announce that we've been named one of Hello Tomorrow's Deep Tech Pioneers! 🌍✨ Join us at the 10th Hello Tomorrow Global Summit on March 13-14, 2025, and connect with the world’s top innovators, industry leaders, investors, and deep tech visionaries. This summit is where groundbreaking ideas meet powerful networks—let's shape the future of deep tech and cancer detection together! 👉https://lnkd.in/g8keznYm Meghan Perkins, PhD Marie Schiltz Michaël Niddam #deeptech #cancerdiagnostics #innovation #hellotomorrow #pioneers
-
-
🌟 Welcome to the Team, Isabela! 🌟 🎉We're thrilled to announce that Isabela Rosas Pavón is joining Proskope as a R&D Scientist Apprentice (Alternante)! 🎉 Isabela is enrolled in the Master's program in Innovation in Biotechnology at Sorbonne University and we're excited to see her contribute fresh perspectives to our projects and research initiatives. Her eagerness to learn and enthusiasm for transforming lives in the field of oncology and cancer detection will undoubtedly be a valuable asset to our team. Please join me in giving her a warm welcome as she embarks on this exciting journey with us! 🚀 #TeamWork #WelcomeToTheTeam #Science #Apprenticeship #Innovation #Research #Alternante Isabela Rosas Pavón Marie Schiltz Meghan Perkins Michaël Niddam
-
-
Proskope a republié ceci
It's a wrap! Last week, batch no.7 of the #4CAccelerator successfully completed the #4CWorkshops 💪 In a total of 15 workshops, hosted by the Stiftung für Medizininnovationen, the startups gained a lot of new knowledge and transferred it directly into their businesses with hands-on exercises. To sum up this time and to quote one of the participants: "We had a mutually joyful and painful time." 😉 A special thank you to the teams for your commitment, your ambition and your passion to bring your innovations into the #healthcare system: Aicendence, EndoSurge, #LiSa, Powered Orthotics, Proskope, QuantiLight, relios.vision and SmartAIs! It was a pleasure to accompany you through the workshops and our 4C Experts Ingo, Christian, Ramona and Henrike are now looking forward to supporting your journey in 1-on-1 coaching for another year. Also, many thanks to Tilmann Petersen from HTGF | High-Tech Gründerfonds and Annika Russo from MBG Baden-Württemberg GmbH for being sparring partners in our final session. -- The program is funded by Start-up BW of the Ministerium für Wirtschaft, Arbeit und Tourismus Baden-Württemberg, the B. Braun Stiftung - der Gesundheit neue Wege bereiten, and the Hector-stiftung. #startupbw #startupbwaccelerator
-
-
Proskope is so excited to be part of the #4CAcceleratorStartups program! Half way in and not only have we already gained invaluable insights and knowledge into understanding and integrating regulatory aspects into our roadmap, but we have also met so many motivated and inspiring people. This support of the 4C program is essential as we work towards bringing our innovative cancer diagnosis biomarker to market more efficiently. Thank you Medical Innovations Incubator GmbH for this incredible opportunity, we are looking forward to the second half of the course! For anyone interested in the program, applications for the 8th batch have just opened, so head over to Medical Innovations Incubator GmbH and get your application in! Thank you for sharing your wisdom with us Lea Renz, Christian Dorn, Ingo Hämmerle and Henrike Stutzki! Marie Schiltz Meghan Perkins #biotech #cancerdiagnostics #accelerator #regulatoryaffairs #MDR
#4CAcceleratorStartups – This week we want to introduce you to the French startup Proskope. ❔ What is your startup working on? Proskope develops a biomarker to accelerate cancer screening and diagnosis. Since our immune system reacts to tumor growth very early, our simple blood test analyzes lymphocytes to differentiate malignant from benign tumors. ❔ Why are you participating in the #4CAccelerator? Integrating regulatory aspects in our roadmap is a must in the in vitro diagnostics sector. The program enables us to include them in our development plan from the beginning, reducing the time it takes to get to market. ❔ What drives your team? See below 👇
-
-
Proskope a republié ceci
📢 Everyone listening to the 11 candidates selected to pitch their project in 4 minutes flat at the QUICK PITCH session of #MEET2WIN MATWIN Unicancer Actipulse Neuroscience® Coralie Dorard ALBUPAD Eya Aloui AtmosR Nathan BECKOUCHE BeLiver Madeleine Moscatelli, PhD Carcinotech Ltd Ishani Malhotra Fungo Keita Augstkalne #onconanor #gautierlaurent Persea Sophie de Ferrières Proskope Marie Schiltz Serendip innovations Alexandre Hill Yomi Pharma Sébastien Arico #MEET2WIN #bordeaux #oncology #innovation #fightagainstcancer
-
-
Dont miss Marie Schiltz and Meghan Perkins pitching Proskope and our exciting solutions to accelerate cancer diagnosis at #MEET2WIN2024 next month! We will also be happy to discuss potential partnerships and collaborations, so if you are attending #MEET2WIN2024, let us know and we can set some time aside 🤝 #cancer #pitch #oncology #innovation #medtech #startup #diagnosis MATWIN Unicancer
Focus on the Quick Pitch session and the 11 selected projects not to miss at #MEET2WIN 2024, European Partnering Convention dedicated to cancer innovation on 16 & 17 May in Bordeaux. Join the event and discover: - Coralie Dorard, Adrien Châtillon Actipulse Neuroscience® - Eya Aloui, ALBUPAD - Nathan Beckouche, Xenia Proton de la Chapelle AtmosR - Madeleine Moscatelli, PhD, Frederic Saltel Beliver - Ishani Malhotra, Carcinotech Ltd - Keita Augstkalne, Fungo - SAYENS Jean-Marc Zeil - Sophie de Ferrières, Persea - Marie Schiltz, Proskope - Alexandre Hill, Serendip innovations - Camille Granet, Yomi Pharma 📢 Info and registration : https://meet2win.fr/ An event MATWIN Unicancer #cancer #pitch #oncology #innovation
-
-
We are delighted to share that Proskope has been selected to join the 4C Accelerator program, along with 7 fellow medtech startups. The program is run by Medical Innovations Incubator GmbH, and focusses on the 4Cs – Commercialization, Certification, Clinical Studies and Copryright! Marie Schiltz, Meghan Perkins and Michaël Niddam attended the kick off program in 📍 Tübingen last week. We are looking forward to the next 14 weeks of discovery and growth! 📈 This accelerator is an excellent opportunity to ensure our development integrates 4Cs requirements from the beginning, reducing the time it takes to get our product to market, accelerating cancer diagnosis to save lives 🚀 #MedTech #4CAccelerator #StartupBW #cancerdiagnosis #IVMD
-